alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 73, Number 10 (Tuesday, January 15, 2008)]
[Notices]
[Pages 2558-2559]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 08-119]


-----------------------------------------------------------------------

OVERSEAS PRIVATE INVESTMENT CORPORATION


January 29, 2008 Annual Public Hearing

    Time and Date: Tuesday, January 29, 2008, 2 p.m.
    Place: Offices of the Corporation, Twelfth Floor Board Room, 1100 
New York Avenue, NW., Washington, DC.
    Status: Hearing OPEN to the Public at 2 p.m.
    Purpose: Annual Public Hearing to afford an opportunity for any 
person to present views regarding the activities of the Corporation.

Procedures

    Individuals wishing to address the hearing orally must provide 
advance notice to OPIC's Corporate Secretary no later than 5 p.m., 
Wednesday, January 23, 2008. The notice must include the individual's 
name, organization, address and telephone number, and a concise summary 
of the subject matter to be presented.
    Oral presentations may not exceed ten (10) minutes. The time for 
individual presentations may be reduced proportionately, if necessary, 
to afford all participants who have submitted a timely request to 
participate, an opportunity to be heard.
    Participants wishing to submit a written statement for the record 
must submit a copy of such statement to OPIC's Corporate Secretary no 
later than 5 p.m., Wednesday, January 23, 2008. Such statements must be 
typewritten, double-spaced and may not exceed twenty-five (25) pages.
    Upon receipt of the required notice, OPIC will prepare an agenda 
for the hearing identifying speakers, setting forth the subject on 
which each participant will speak, and the time allotted for each 
presentation. The agenda will be available at the hearing.

[[Page 2559]]

    A written summary of the hearing will be compiled, and such summary 
will be made available, upon written request to OPIC's Corporate 
Secretary, at the cost of reproduction.
    Contact Person for Information: Information on the hearing may be 
obtained from Connie M. Downs at (202) 336-8438, via facsimile at (202) 
408-0136, or via e-mail at <a href="/cdn-cgi/l/email-protection#e281868d958ca28d928b81cc858d94"><span class="__cf_email__" data-cfemail="7013141f071e301f0019135e171f06">[email protected]</span></a>.
    Supplementary Information: OPIC is a U.S. Government agency that 
provides, on a commercial basis, political risk insurance and financing 
in friendly developing countries and emerging democracies for 
environmentally sound projects that confer positive developmental 
benefits upon the project country while creating employment in the U.S. 
OPIC is required by section 231A(c) of the Foreign Assistance Act of 
1961, as amended (the ``Act'') to hold at least one public hearing each 
year.

    Dated: January 11, 2008.
Connie M. Downs,
OPIC Corporate Secretary.
[FR Doc. 08-119 Filed 1-11-08; 1:17 pm]
BILLING CODE 3210-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Exhibit 32.1
   CERTIFICATION PURSUANT TO 18 U.S.C. SEC. 1350
 (SECTION 906 OF SARBANES-OXLEY ACT OF 2002)
 
  In connection with the Quarterly Report of Rhino Productions, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ya Kun Song, Chief Executive Officer and Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that:
  (1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
  (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
  Dated: May 16, 2011
   /s/ Ya Kun Song
 Ya Kun Song
 Chief Executive Officer and Chief Financial Officer (principal executive and financial officer)
---

EXHIBIT 23





CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM








We consent to the incorporation by reference in Registration Statements on Form S-8 (File Nos. 333-20793, 333-31245, 333-87842, 333-135462 and 333-167373), the Registration Statements on Form  S-3 (File Nos. 333-20699, 333-54738, 333-133632, 333-157630 and 333-158714) and the Registration Statement on Form S-3D (File no. 333-167374) of Stewardship Financial Corporation of our report dated March 30, 2011 relating to the consolidated financial statements appearing in this annual report on Form 10-K.






Crowe Horwath LLP




Livingston, New Jersey


March 30, 2011
I 

115TH CONGRESS 

2D SESSION H. R. 5547 

To amend the Violence Against Women Act of 2000 to reauthorize the 

grant program for education, training, and enhanced services to end 

violence against and abuse of women with disabilities. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 18, 2018 

Mr. CALVERT introduced the following bill; which was referred to the 

Committee on the Judiciary 

A BILL 

To amend the Violence Against Women Act of 2000 to 

reauthorize the grant program for education, training, 

and enhanced services to end violence against and abuse 

of women with disabilities. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Certainty, Assistance, 

5 and Relief for Everyone Act’’ or the ‘‘CARE Act’’. 


dlhill on DSK3GLQ082PROD with BILLS
2 

•HR 5547 IH

1 SEC. 2. REAUTHORIZATION OF GRANT PROGRAM FOR EDU2 CATION, TRAINING, AND ENHANCED SERV3 ICES TO END VIOLENCE AGAINST AND ABUSE 

4 OF WOMEN WITH DISABILITIES. 

5 Section 1402 of the Violence Against Women Act of 

6 2000 (34 U.S.C. 20122) is amended— 

7 (1) in subsection (e), by striking ‘‘2018’’ and 

8 inserting ‘‘2023’’; and 

9 (2) by adding at the end the following new sub10 section: 

11 ‘‘(f) REPORT.—Not later than 1 year after the date 

12 of enactment of the Certainty, Assistance, and Relief for 

13 Everyone Act, the Attorney General shall issue a report 

14 identifying and describing best practices for State, local, 

15 and tribal law enforcement officers and prosecutors in in16 vestigating and prosecuting sexual assault cases involving 

17 the victimization of individuals with disabilities.’’. 

Æ 


dlhill on DSK3GLQ082PROD with BILLS
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5648 Introduced in House (IH)]

<DOC>

115th CONGRESS
  2d Session
                                H. R. 5648

  To amend title 28, United States Code, to provide for Supreme Court 
 original jurisdiction over certain immigration actions, and for other 
                               purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                             April 27, 2018

 Mr. Gohmert introduced the following bill; which was referred to the 
                       Committee on the Judiciary

_______________________________________________________________________

                                 A BILL

 
  To amend title 28, United States Code, to provide for Supreme Court 
 original jurisdiction over certain immigration actions, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``INA Jurisdiction Act of 2018''.

SEC. 2. SUPREME COURT JURISDICTION OVER CERTAIN IMMIGRATION ACTIONS.

    Section 1251 of title 28, United States Code, is amended by adding 
at the end the following:
    ``(c) The Supreme Court and any immigration court, established 
under the immigration laws (as such term is defined in section 101 of 
the Immigration and Nationality Act) are the only courts that shall 
have jurisdiction and in which a claimant shall have standing to raise 
issues of immigration, naturalization, refugee status, asylum, and any 
other related matter or case involving a claimed legal right to enter 
or remain in the United States, or any case or controversy of any 
provision of the immigration laws, or any order issued or rule made 
pursuant thereto.''.
                                 <all>
```
[Federal Register Volume 72, Number 8 (Friday, January 12, 2007)]
[Notices]
[Page 1551]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-97]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Heart, Lung, and Blood Initial Review Group, 
Clinical Trials Review Committee.
    Date: February 26-27, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Intercontinental Harbor Courtyard Baltimore, 550 Light 
Street, Baltimore, MD 20202.
    Contact Person: Patricia A. Haggerty, PhD, Section Chief, 
Clinical Studies and Training Scientific Review Group, Review 
Branch, Division of Extramural Research Activities, National Heart, 
Lung, and Blood Institute, NIH, 6701 Rockledge Drive, Room 7194, MSC 
7924, Bethesda, MD 20892, 301/435-0288, <a href="/cdn-cgi/l/email-protection#620a03050507101612220c0a0e000b4c0c0b0a4c050d14"><span class="__cf_email__" data-cfemail="c9a1a8aeaeacbbbdb989a7a1a5aba0e7a7a0a1e7aea6bf">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: January 4, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-97 Filed 1-11-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
* Pursuant to 5 TH C IR

. R. 47.5, the Court has determined that this opinion should not be

published and is not precedent except under the limited circumstances set forth in 5 TH C IR

. R. 47.5.4. UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 97-50211 Summary Calendar

UNITED STATES OF AMERICA, Plaintiff-Appellee,

versus

RAUL ESPINOZA-MONDRAGON, also known as Jose Espinoza-Portillo, Defendant-Appellant.

Appeal from the United States District Court

For the Western District of Texas (DR-94-CR-35-2 & DR-96-CV-74)

April 27, 1998

Before POLITZ, Chief Judge, KING and DENNIS, Circuit Judges.

PER CURIAM: *

Raul Espinoza-Mondragon (“Espinoza”), a federal prisoner, appeals the

district court’s denial of his motion to vacate, set aside, or correct sentence pursuant

to 28 U.S.C. § 2255. Espinoza contends that the district court erred in failing to1 Bonvillian v. Blackburn , 780 F.2d 1248 (5th Cir. 1986); Blackledge v. Allison , 431

U.S. 63 (1977) (declarations under oath in open court are entitled to strong presumption of veracity).

2 Hill v. Lockhart , 474 U.S. 52 (1985).

2 hold an evidentiary hearing to address his affidavits, which allegedly support his

cla im that his guilty plea to drug-trafficking offenses was invalid because his

attorney performed ineffectively. The affidavits state only that Espinoza does not

speak or read English, a fact that the court must have been aware of when it

accepted his guilty plea; an interpreter then was present for Espin oza. The

affidavits contribute nothing relevant to Espinoza’s substantive claim. The

transcript of the rearraignment shows that Espinoza voluntarily and knowingly

ente red his guilty plea. 1 Espinoza’s conclusional claims that his attorney’s

ineffective assistance caused him to enter his guilty plea are devoid of merit. 2

Espinoza’s request for the appointment of counsel for appeal is DENIED.

AFFIRMED.
<PAGE>
                                                                      EXHIBIT 24
 
                              LARSCOM INCORPORATED
                               POWER OF ATTORNEY
 
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears
below hereby constitutes and appoints George M. Donohoe as his attorney-in-fact,
with full power of substitution, for him in any and all capacities, to sign any
and all amendments to this Form 10-K for the year ending December 31, 1998, and
to file the same, exhibits and other documents in connection therewith, with
Securities and Exchange Commission, hereby ratifying and confirming our
signatures as they may be signed by our said attorney to any and all amendments
to said Form 10-K.
 
             NAME                         TITLE                    DATE
------------------------------  --------------------------  -------------------
 
    /s/ GEORGE M. DONOHOE
------------------------------  Acting Chief Executive        March 29, 1999
      George M. Donohoe           Officer
 
                                Vice President, Finance
      /s/ BRUCE D. HORN           and Chief Financial
------------------------------    Officer (Chief Financial    March 26, 1999
        Bruce D. Horn             Officer and Principal
                                  Accounting Officer)
 
       /s/ PAUL E. GRAF
------------------------------  Director                      March 29, 1999
         Paul E. Graf
 
       /s/ DONALD GREEN
------------------------------  Director                      March 23, 1999
         Donald Green
 
     /s/ DONALD G. HEITT
------------------------------  Director                      March 25, 1999
       Donald G. Heitt
 
   /s/ LAWRENCE D. MILLIGAN
------------------------------  Director                      March 23, 1999
     Lawrence D. Milligan
 
     /s/ HARVEY L. POPPEL
------------------------------  Director                      March 23, 1999
       Harvey L. Poppel
 
    /s/ JOSEPH F. SMORADA
------------------------------  Director                      March 29, 1999
      Joseph F. Smorada
Exhibit 32
                    CERTIFICATION PURSUANT TO
                         18 U.S.C. 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection with the Annual Report of AEI Income & Growth Fund
XXII  Limited Partnership (the "Partnership") on Form 10-KSB  for
the  period ended December 31, 2003, as filed with the Securities
and  Exchange  Commission on the date hereof (the "Report"),  the
undersigned, Robert P. Johnson, President of AEI Fund  Management
XXI,  Inc., the Managing General Partner of the Partnership,  and
Patrick  W. Keene, Chief Financial Officer of AEI Fund Management
XXI,  Inc., each certify, pursuant to 18 U.S.C. 1350, as  adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

     1.   The  Report  fully  complies with the  requirements  of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934; and

     2.   The   information  contained  in  the   Report   fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Partnership.


                           /s/ Robert P Johnson
                               Robert P. Johnson, President
                               AEI Fund Management XXI, Inc.
                               Managing General Partner
                               March 19, 2004



                           /s/ Patrick W Keene
                               Patrick W. Keene, Chief Financial Officer
                               AEI Fund Management XXI, Inc.
                               Managing General Partner
                               March 19, 2004
[Federal Register Volume 72, Number 40 (Thursday, March 1, 2007)]
[Notices]
[Page 9340]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-912]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


National Institute for Occupational Safety and Health; Decision 
To Evaluate a Petition To Designate a Class of Employees at Hanford in 
Richland, Washington, To Be Included in the Special Exposure Cohort

AGENCY: National Institute for Occupational Safety and Health (NIOSH), 
Department of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Health and Human Services (HHS) gives notice 
as required by 42 CFR 83.12(e) of a decision to evaluate a petition to 
designate a class of employees at Hanford in Richland, Washington, to 
be included in the Special Exposure Cohort under the Energy Employees 
Occupational Illness Compensation Program Act of 2000. The initial 
proposed definition For the class being evaluated, subject to revision 
as warranted by the evaluation, is as follows:
    Facility: Hanford.
    Location: Richland, Washington.
    Job Titles and/or Job Duties: All roving maintenance carpenters and 
apprentice carpenters who worked in the 100, 200, 300, and 400 Areas.
    Period of Employment: April 25, 1967 through February 1, 1971.

FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of 
Compensation Analysis and Support, National Institute for Occupational 
Safety and Health (NIOSH), 4676 Columbia Parkway, MS C-46, Cincinnati, 
OH 45226, Telephone 513-533-6800 (this is not a toll-free number). 
Information requests can also be submitted by e-mail to <a href="/cdn-cgi/l/email-protection#b8f7fbf9ebf8fbfcfb96fff7ee"><span class="__cf_email__" data-cfemail="c9868a889a898a8d8ae78e869f">[email protected]</span></a>.

    Dated: February 22, 2007.
John Howard,
Director, National Institute for Occupational Safety and Health.
[FR Doc. 07-912 Filed 2-28-07; 8:45 am]
BILLING CODE 4163-19-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 72, Number 40 (Thursday, March 1, 2007)]
[Notices]
[Page 9344]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-927]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; Partnerships to Improve Diagnosis 
and Treatment of Selected Drug-Resistant Healthcare-Association 
Infections.
    Date: March 13, 2007.
    Time: 8:30 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Gaithersburg Marriott Washingtonian Center, 9751 
Washingtonian Boulevard, Salon G of the Grant Ballroom, 
Gaithersburg, MD 20878.
    Contact Person: Alec Ritchie, Ph.D, Scientific Review 
Administrator, Scientific Review Program, Division of Extramural 
Activities, National Institutes of Health/NIAID/DHHS, 6700 B 
Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616, 301-435-1614, 
<a href="/cdn-cgi/l/email-protection#19786b706d7a71707c59777078707d37777071377e766f"><span class="__cf_email__" data-cfemail="dfbeadb6abbcb7b6ba9fb1b6beb6bbf1b1b6b7f1b8b0a9">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: February 20, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-927 Filed 2-28-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>